Replies to post #2149 on Enanta Pharmaceuticals Inc (ENTA)

[vinmantoo]

What takes a lot of time is generating enough API for high-volume output. Producing small amounts of the drug for early-stage clinical trials is not a problem.

Agreed. My point was about manufacturing large quantities post-approval, which is why I say way down the road.